Provider review
Ro Body review: pricing, pharmacy, and evidence status
Released: · Last reviewed: · By Dr. Parmis
Ro Body offers GLP-1 medications through telehealth. Every price, credential and pharmacy claim below is labeled by evidence status and read date.
Ro Body has no usable published price on file. It does not name a dispensing pharmacy. It is not scored in the November 20, 2026 re-score because its pages could not be read.
Rank and score
Ro Body is not scored in the November 20, 2026 re-score: ro.co returned HTTP 403 to every read on November 10 and 20, 2026 (portfolio re-read: unreachable). Giving it points, or zeros, for pages we could not read would misstate what it discloses. See the methodology.
Pricing by plan
| Medication | Formulation | Plan | Price | Source | Evidence |
|---|---|---|---|---|---|
| semaglutide (Wegovy) | brand injectable, FDA-approved | month-to-month | $348/mo | not published · read 2026-07-06 | Unverified — no source on file |
"Provider reported" means the figure comes from the company's own site or intake flow and has not been independently corroborated by GLP Ranked.
Clinical model
Not disclosed on the pages we could read. We could not identify the medical group or prescriber entity this company uses.
Accreditation: we have not verified any accreditation or certification claim for Ro Body against the issuing body. If a program cites one (for example LegitScript), check the issuer's public lookup before you rely on it.
Pharmacy & compliance
Not publicly disclosed — the fulfilling pharmacy or outsourcing facility is not named. Pharmacy transparency is worth 15 of 100 points under our v4.1 rubric.
State availability
State-by-state availability is not independently verified.
Who this suits — and who it doesn't
Ro Body may suit patients who want a standard-dose program and are comfortable proceeding without a named dispensing pharmacy disclosed up front.It is a weaker fit for patients who need written proof of pharmacy accreditation before paying; ask the company for it.
Terms to check before you pay: cancellation and refund terms could not be read in this re-score; published support response times: not published.
Sources
- FDA: Warning letters index (searched for this program) — Regulator database, captured 2026-11-20
- FDA: Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (content current October 1, 2026) — Regulator page, captured 2026-11-20
- FDA: Compounding: Inspections, Recalls, and other Actions (content current October 22, 2026) — Regulator list, captured 2026-11-21
Cite this page
GLP Ranked. "Ro Body review: pricing, pharmacy, and evidence status." https://glpranked.com/providers/ro-body/
GLP Ranked. "Ro Body review: pricing, pharmacy, and evidence status." https://glpranked.com/providers/ro-body/